ライフサイエンスコーパス: informed consent

1 y assigned to treatment who provided written informed consent).

2 with paracetamol overdose, and gave written informed consent.

3 nal review boards, and all participants gave informed consent.

4 d all patients or their parents gave written informed consent.

5 , with a waiver of the HIPAA requirement for informed consent.

6 study, and all participants provided written informed consent.

7 nge, 70.4-101.2 years) who had given written informed consent.

8 ive study, with waiver of the need to obtain informed consent.

9 nnaire was used to collect data after verbal informed consent.

10 laration Good Clinical Practice with written informed consent.

11 overnment, and all participants gave written informed consent.

12 d-approved study after they provided written informed consent.

13 e study and waived the requirement to obtain informed consent.

14 All subjects provided written informed consent.

15 ew board-approved study received a waiver of informed consent.

16 board and was HIPAA compliant with waiver of informed consent.

17 hics committee approved the study and waived informed consent.

18 All patients provided written informed consent.

19 approved this study and waived the need for informed consent.

20 proved this study, and all participants gave informed consent.

21 f prospectively acquired data with waiver of informed consent.

22 ional review board and all participants gave informed consent.

23 All subjects provided written informed consent.

24 obtained, with waiver of the need to obtain informed consent.

25 ountability Act compliant study with written informed consent.

26 committee, and all participants gave written informed consent.

27 t >/= 10 kg, ability to take oral drugs, and informed consent.

28 f 6 major ROP centers whose parents provided informed consent.

29 board approval was obtained, with waiver of informed consent.

30 y depend on risk versus benefit analysis and informed consent.

31 l review board, and all subjects gave signed informed consent.

32 oved by the ethics board and did not require informed consent.

33 retrospective study, with waiver of written informed consent.

34 Participants gave written informed consent.

35 All patients gave written informed consent.

36 ved this retrospective study, with waiver of informed consent.

37 ics committee, and all subjects gave written informed consent.

38 onal review board, and all participants gave informed consent.

39 study and all participants provided written informed consent.

40 pproved the study, and all participants gave informed consent.

41 tional review board-approved with waivers of informed consent.

42 view board, which waived the requirement for informed consent.

43 onal review board waived the requirement for informed consent.

44 hared with prospective donors at the time of informed consent.

45 by institutional review boards with written informed consent.

46 nal review board approval, and patients gave informed consent.

47 titutional review board provided a waiver of informed consent.

48 the institutional review board with patient informed consent.

49 All participants provided written informed consent.

50 w study and waived the requirement to obtain informed consent.

51 committee, and all participants gave written informed consent.

52 ethics board approved this study and waived informed consent.

53 retrospective study from the requirement for informed consent.

54 institutional review board with a waiver of informed consent.

55 ed clinical trial, and all patients provided informed consent.

56 e care units after non-cardiac surgery, with informed consent.

57 ompliant retrospective study, with waiver of informed consent.

58 approved this retrospective study and waived informed consent.

59 and institutional review board-approved with informed consent.

60 ients and the control group provided written informed consent.

61 board-approved and participants gave written informed consent.

62 ospective multicenter study with a waiver of informed consent.

63 overnment, and all participants gave written informed consent.

64 d all participating parents provided written informed consent.

65 ics committee, and participants gave written informed consent.

66 approval, and all participants gave written informed consent.

67 iew board, and all participants gave written informed consent.

68 candidacy for surgical intervention provided informed consent.

69 val, and patients in the CLQ cohort provided informed consent.

70 monitoring were included in the study, after informed consent.

71 screening FFDM during 2004-2013 and provided informed consent.

72 All patients provided written informed consent.

73 rea for 3 or more years, and able to provide informed consent.

74 tive single-arm study, and patients provided informed consent.

75 proved this HIPAA-compliant study and waived informed consent.

76 board approval and all patients gave written informed consent.

77 r this HIPAA-compliant study, with waiver of informed consent.

78 d this HIPAA-compliant study, with waiver of informed consent.

79 arch ethics committee and was performed with informed consent.

80 review board-approved study was exempt from informed consent.

81 Patients gave written informed consent.

82 board approval was obtained, with waiver of informed consent.

83 All patients gave informed consent.

84 titutional review board approval and written informed consent.

85 ed for this study; all patients gave written informed consent.

86 After providing informed consent, 24 adult volunteers underwent imaging

87 wing institutional review board approval and informed consent, 26 subjects (16 men, 10 women; mean ag

88 d-approved, prospectively conducted (written informed consent acquired), cross-sectional study perfor

89 mpliant study was performed with a waiver of informed consent after institutional review board approv

90 After informed consent, all patients underwent antiviral thera

91 .4%] male and 116 [49.8%] female; 80 with no informed consent allegation and 153 who cited lack of in

92 The most common informed consent allegations were failure to explain ris

93 Informed consent allegations were significantly associat

94 ty payments, malpractice lawsuits, including informed consent allegations, still present a time, mone

95 One subject withdrew informed consent and 99 subjects (63 males) were analyze

96 Following informed consent and administration of a study questionn

97 Failure to obtain informed consent and associated medical malpractice case

98 Participating patients and families gave informed consent and chose between nonoperative manageme

99 mated in prior studies-with implications for informed consent and design for clinical trials targetin

100 Better understanding of LOS is necessary for informed consent and discharge planning.

101 Materials and Methods Written informed consent and institutional ethics committee appr

102 n nine self-declared healthy volunteers with informed consent and institutional review board approval

103 ined for this HIPAA-compliant investigation; informed consent and patient assent (as indicated) were

104 Parental informed consent and subject assent were obtained from a

105 considerations, including issues surrounding informed consent and the uncertainty of the results of g

106 Risk estimation is critical for appropriate informed consent and varies substantially across living

107 In sum, 971 subjects granted informed consent and were enrolled resulting in 904 nond

108 Participants gave informed consent and were instructed on use of oral flui

109 nasolacrimal duct obstruction who gave fully informed consent and who had no lid malpositions or cana

110 e, 57.1 years; range, 50-69 years), who gave informed consent and who had suspicious screening mammog

111 sign adopted for a sham surgery CT; specific informed consent, and economic issues.

112 ivacy, confidentiality, professionalism, and informed consent, and increase the potential for undue i

113 patient assessment, shared decision making, informed consent, and preoperative patient optimization,

114 , selecting appropriate endpoints, ethics of informed consent, and regulatory issues.

115 ls and Methods All subjects provided written informed consent, and the protocol was approved by the u

116 e not too impaired to comprehend and provide informed consent, and, for this paper, who tested HIV ne

117 sponse; pain caused by cIAI; able to provide informed consent; and diagnosis of cIAI with sonogram or

118 To investigate the failure to obtain informed consent as an allegation in medical malpractice

119 With informed consent, blood samples were obtained from 50 pa

120 fter institutional review board approval and informed consent, consecutive LT recipients were include

121 After obtaining patient informed consent, demographics, clinical and health-rela

122 Prerequisites are as follows: obtaining informed consent; evidencing of an allergen by skin pric

123 Informed consent for cell therapy studies in patients wi

124 of stem cell donors who had provided written informed consent for stem cell donation and use of anony

125 Patients gave their written informed consent for study enrollment.

126 Written informed consent for study participation was obtained.

127 All patients provided written informed consent for study participation, the ablation p

128 oved study, all patients with ADPKD provided informed consent; for control subjects, informed consent

129 oval was obtained and all patients signed an informed consent form.

130 titutional review board approval and written informed consent from all participants were obtained.

131 titutional review board approval and written informed consent from all patients were obtained.

132 search ethics committee approval and written informed consent from each subject, were included in thi

133 titutional review board-approved study, with informed consent from patients.

134 After obtaining informed consent from the readers, 12 CT colonography fl

135 ve more permanent injuries compared with the informed consent group (46 [57.5%] vs 63 [42.0%], P = .0

136 control group, and 47.9 [13.3] years in the informed consent group).

137 e, found to have inadequate documentation of informed consent, immediately withdrew consent, or rando

138 an exception from having to acquire explicit informed consent in emergency circumstances.

139 ere is a paucity of literature investigating informed consent in spinal surgery malpractice.

140 All patients provided informed consent in this institutional review board-appr

141 Materials and Methods Written informed consent in this institutional review board-appr

142 d Methods Thirty recruited patients provided informed consent in this institutional review board-appr

143 After informed consent, in one visit, subjects underwent cardi

144 compliant retrospective study with waiver of informed consent included patients with asymptomatic sma

145 rd-approved retrospective study, with waived informed consent, included 244 patients with pathologica

146 Lack of informed consent is an important cause of medical malpra

147 tional review boards approved the study, and informed consent is obtained before study enrollment.

148 hods Institutional review board approval and informed consent of all participants were obtained.

149 eview board-approved study, with the written informed consent of all patients, two-dimensional magnet

150 or hepatectomy and to provide a database for informed consent of prospective donors.

151 Registry between 2006 and 2012 and provided informed consent or a waiver for research, in compliance

152 Patients provided written informed consent, or, at select sites, there was an exce

153 ratification systems could assist individual informed consent, preoperative surgical planning, safe a

154 erials and Methods All patients gave written informed consent prior to inclusion in this institutiona

155 eeks, and all men were enrolled with written informed consent prior to treatment.

156 ul to develop a standardized, donor-tailored informed consent procedure for live donor nephrectomy.

157 This may also help standardize the informed consent procedure.

158 The informed consent process for recruitment of patients wit

159 r language that researchers could use in the informed consent process to disclose the legal risks.

160 e the legal risks to participants during the informed consent process, and whether researchers would

161 These include an enhanced informed consent process, the stamping of the Kezzler co

162 of obtaining the information as part of the informed consent process.

163 cated about all risks and details during the informed consent process.

164 Informed consent processes should include legally author

165 on 4 key areas to improve HABP/VABP trials: informed consent processes/practices, protocol design, c

166 st 1, 2012, to July 30, 2014, and waived the informed consent requirement.

167 study in which all subjects provided written informed consent, six patients with relapsing-remitting

168 ich provides opportunities for education and informed consent, the development of standards and pathw

169 a team, the cultural challenge of obtaining informed consent through an interpreter, and the stress

170 Participants provided written informed consent to a protocol that was approved by a lo

171 ey transplant candidates (KTCs) must provide informed consent to accept kidneys from increased risk d

172 een patients with biopsy-proven PCa provided informed consent to be included in this institutional hu

173 All subjects gave informed consent to participate and were examined using

174 re part of the follow-on clinical trial gave informed consent to participate in a longitudinal neuroi

175 ll players (age range, 52-65 years) provided informed consent to participate in this cross-sectional

176 s had no evidence of having provided written informed consent to participate.

177 ng dementia, and 634 (9.3%) provided written informed consent to participate.

178 All participants provided informed consent to take part in the trial.

179 ls and Methods All participants gave written informed consent to undergo brain magnetic resonance ima

180 uch as IRB disaster preparedness activities, informed consent, vulnerable populations, confidentialit

181 ional review board approval was obtained and informed consent waived for this HIPAA-compliant retrosp

182 ional review board approval was obtained and informed consent waived for this retrospective noninferi

183 In this institutional review board-approved, informed consent-waived, HIPAA-compliant, retrospective

184 University of Toronto Research Ethics Board; informed consent was not required.

185 on and the poor prognosis to the patient, an informed consent was obtained after she opted for medica

186 An informed consent was obtained after she opted for medica

187 Informed consent was obtained for MR imaging.

188 ood challenge test for udon (wheat noodles), informed consent was obtained from 49 subjects.

189 Written informed consent was obtained from 67 consecutive patien

190 had institutional review board approval, and informed consent was obtained from 72 patients with brea

191 onal Research Ethical Committee, and written informed consent was obtained from all individuals.

192 Written informed consent was obtained from all participants befo

193 proved by the local ethics board and written informed consent was obtained from all participants.

194 Written informed consent was obtained from all participants.

195 Written informed consent was obtained from all participants.

196 of Kanton Bern and Kanton Zurich, and signed informed consent was obtained from all participants.

197 eview board approved the study protocol, and informed consent was obtained from all participants.

198 Informed consent was obtained from all participants.

199 34.3 +/- 6.5 y) were recruited, and written informed consent was obtained from all participants.

200 Materials and Methods Written informed consent was obtained from all patients in the M

201 Materials and Methods Written informed consent was obtained from all patients, and the

202 Written informed consent was obtained from all patients, and the

203 l Research Ethics Service Committee; written informed consent was obtained from all patients.

204 institutional review board approval; written informed consent was obtained from all patients.

205 by the local institutional review board, and informed consent was obtained from all patients.

206 approved by the institutional review board; informed consent was obtained from all patients.

207 pproved by our ethics committee, and written informed consent was obtained from all patients.

208 d by the local ethics committee, and written informed consent was obtained from all patients.

209 Written informed consent was obtained from all patients.

210 Written informed consent was obtained from all patients.

211 Informed consent was obtained from all patients.

212 Informed consent was obtained from all patients.

213 the institutional review board, and written informed consent was obtained from all study participant

214 cal committees on human studies, and written informed consent was obtained from all subjects before e

215 by the local ethical committee, and written informed consent was obtained from all subjects before e

216 by the local ethics committees, and written informed consent was obtained from all subjects prior to

217 Written informed consent was obtained from all subjects.

218 had institutional review board approval, and informed consent was obtained from all subjects.

219 eiden University Medical Center, and written informed consent was obtained from all subjects.

220 Written informed consent was obtained from all subjects.

221 Informed consent was obtained from all subjects.

222 approved by the institutional review board; informed consent was obtained from all subjects.

223 institutional HIPAA-compliant study; written informed consent was obtained from all subjects.

224 Informed consent was obtained from all subjects.

225 d by the local ethics committee, and written informed consent was obtained from each patient.

226 Written informed consent was obtained from each subject.

227 d by the institutional board review; written informed consent was obtained from healthy subjects and

228 Informed consent was obtained from parents and children

229 Written informed consent was obtained from patients or their par

230 Informed consent was obtained from patients.

231 Informed consent was obtained prior to enrollment.

232 utional review board-approved protocol where informed consent was obtained, 50 lung cancers that mani

233 Materials and Methods After written informed consent was obtained, 8869 women (age range, 29

234 ional review board approval with a waiver of informed consent was obtained, a HIPAA-compliant retrosp

235 roved this retrospective study and waiver of informed consent was obtained.

236 , and interviews occurred only after written informed consent was obtained.

237 was approved by the ethics review board, and informed consent was obtained.

238 he institutional research board, and written informed consent was obtained.

239 Written informed consent was obtained.

240 the institutional review board, and written informed consent was obtained.

241 Written informed consent was obtained.

242 the institutional review boards, and written informed consent was obtained.

243 the prospective study protocol, and written informed consent was obtained.

244 datasets were acquired at 3 T after written informed consent was obtained.

245 Informed consent was provided according to the last will

246 Written informed consent was waived because all the patients rec

247 onal review board approval was obtained, and informed consent was waived for this HIPAA-compliant ret

248 onal review board approval was obtained, and informed consent was waived in this HIPAA-compliant retr

249 review board, and the requirement to obtain informed consent was waived.

250 The requirement to obtain informed consent was waived.

251 roved by the institutional review board, and informed consent was waived.

252 chart review, and the requirement to obtain informed consent was waived.

253 board approved this retrospective study and informed consent was waived.

254 The requirement to obtain informed consent was waived.

255 pproval was obtained and the requirement for informed consent was waived.

256 ics committee, and the requirement to obtain informed consent was waived.

257 pective, HIPAA-compliant, multicenter study; informed consent was waived.

258 The requirement to obtain written informed consent was waived.

259 tional review board, and the requirement for informed consent was waived.

260 d by the institutional ethics committee, and informed consent was waived.

261 ture of the study, the requirement to obtain informed consent was waived.

262 rg (ethics approval number, S-320/2012), and informed consent was waived.

263 s approved by the local ethics committee and informed consent was waived.

264 was Institutional Review Board approved, and informed consent was waived.

265 review board, and the requirement to obtain informed consent was waived.

266 l review board approved and HIPAA compliant; informed consent was waived.

267 ided informed consent; for control subjects, informed consent was waived.

268 this retrospective HIPAA-compliant study and informed consent was waived.

269 onal review board approval was obtained, and informed consent was waived.

270 tional review board, and the requirement for informed consent was waived.

271 l review board approved; the need for signed informed consent was waived.

272 The need for informed consent was waived.

273 ethical review board, and the need to obtain informed consent was waived.

274 was obtained, and the requirement to obtain informed consent was waived.

275 ional review board, and the need for written informed consent was waived.

276 Informed consent was waived.

277 had institutional review board approval, and informed consent was waived.

278 onal review board approval, and the need for informed consent was waived.

279 onal review board; the requirement to obtain informed consent was waived.

280 Written informed consent was waived.

281 onal review board approval, with a waiver of informed consent, was obtained for this analysis of clin

282 s in English or siSwati, and provide written informed consent were eligible for the study.

283 In addition, allegations of informed consent were found to be predictive of a defens

284 onal review board exemption and a waiver for informed consent were granted to the author with an acad

285 titutional review board approval and written informed consent were obtained for the Effect of Iso-osm

286 titutional review board approval and written informed consent were obtained from all patients for the

287 titutional review board approval and written informed consent were obtained from all subjects.

288 d Methods After ethical approval and patient informed consent were obtained, two pretreatment T2-weig

289 titutional review board approval and written informed consent were obtained.

290 Ethics approval and informed consent were obtained.

291 Materials and Methods Ethics approval and informed consent were obtained.

292 Institutional ethics committee approval and informed consent were obtained.

293 local ethics committee approval and written informed consent were obtained.

294 hods Institutional review board approval and informed consent were obtained.

295 hods Institutional review board approval and informed consent were obtained.

296 omographic (CT) angiography and who provided informed consent were prospectively randomized to the us

297 s and Methods Institutional review board and informed consent were waived for this study.

298 ined and eligible individuals, who had given informed consent, were vaccinated and followed up for 21

299 consent allegation and 153 who cited lack of informed consent) who underwent spinal surgery and filed

300 y the institutional review board and written informed consent with HIPAA authorization was obtained.